Streetbeat News

UTRS

Minerva Surgical Inc

Employees

182

Industry

Surgical and Medical Instrument Manufacturing

minerva surgical, inc. is a medical device start-up company based in the silicon valley; redwood city, ca. the company's efforts are focused on women's healthcare. currently, minerva surgical's development projects are aimed at delivering next generation products for the treatment of abnormal uterine bleeding, a condition that affects almost 1 in 5 women. the company was founded in 2008 by a group of experienced medical device industry veterans. these founders have successfully delivered numerous medical device based therapies to patients over a span of 30 years.

Open

0.00

Mkt cap

888

Volume

High

1.48

P/E Ratio

N/A

52-wk high

3.49

Low

0.00

Div yield

N/A

52-wk low

0.00

In Tuesday's after-market session, several healthcare stocks experienced significant movements. Phio Pharma (PHIO) saw a 19.6% increase, while Lucy Scientific Discovery (LSDI) rose by 9.34%. Aclaris Therapeutics (ACRS) went up by 8.47%, and Minerva Surgical (UTRS) by 8.36%. Pasithea Therapeutics (KTTA) and Phreesia (PHR) also saw gains of 6.77% and 5.76%, respectively. On the downside, Allarity Therapeutics (ALLR) dropped by 8.1%, InVivo Therapeutics (NVIV) by 7.06%, Longeveron (LGVN) by 6.2%, Surrozen (SRZN) by 6.01%, Impel Pharmaceuticals (IMPL) by 5.58%, and BioCardia (BCDA) by 5.49%.

Portfolio Pulse from Benzinga Insights

December 05, 2023 | 9:31 pm

In Thursday's after-market session, several healthcare stocks experienced significant movements. Altimmune (ALT) saw a 45.2% increase, while Ampio Pharmaceuticals (AMPE) dropped by 20.5%. Other notable gainers include NovaBay Pharmaceuticals (NBY), China Pharma Holding (CPHI), NeuBase Therapeutics (NBSE), Minerva Surgical (UTRS), and Akanda (AKAN). On the losing side, Corbus Pharmaceuticals (CRBP), Eagle Pharmaceuticals (EGRX), bioAffinity Technologies (BIAF), Quoin Pharmaceuticals (QNRX), and LumiraDx (LMDX) saw declines in their stock prices.

Portfolio Pulse from Benzinga Insights

November 30, 2023 | 9:31 pm

Minerva Surgical (NASDAQ:UTRS) reported Q3 earnings with an EPS loss of $(0.81), which was better than the expected $(1.00) estimate. However, their sales of $11.96M fell short of the $13.21M estimate, marking a 4.95% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:05 pm

During Monday's pre-market session, several health care stocks experienced significant movement. AnaptysBio, Ontrak, ABVC BioPharma, Cadrenal Therapeutics, AcelRx Pharmaceuticals, and Geovax Labs saw their shares rise, with AnaptysBio leading the gainers with a 17.9% increase. Conversely, Leap Therapeutics, Minerva Surgical, Addex Therapeutics, Longeveron, Senti Biosciences, and CytoMed Therapeutics saw their shares fall, with Leap Therapeutics leading the losers with a 14.1% decrease.

Portfolio Pulse from Benzinga Insights

October 09, 2023 | 1:06 pm

The article lists the stocks that gained and lost the most in Monday's mid-day session. Among the gainers, AERWINS Technologies Inc. (NASDAQ:AWIN) shares climbed 86.1% after the company said it is considering strategic alternatives for its non-core operations. Among the losers, SmileDirectClub, Inc. (NASDAQ:SDC) shares dipped 62% after the company filed for Chapter 11 bankruptcy.

Portfolio Pulse from Lisa Levin

October 02, 2023 | 5:00 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Gainers included MSP Recovery (LIFW), Biohaven (BHVN), SeaStar Medical Holding (ICU), Context Therapeutics (CNTX), Streamline Health Solns (STRM), and Galecto (GLTO). Losers included Sharps Technology (STSS), Minerva Surgical (UTRS), Know Labs (KNW), Tharimmune (THAR), Femasys (FEMY), and Synlogic (SYBX).

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 5:31 pm

Several stocks experienced significant movement in Wednesday's mid-day session. ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 152.8% after announcing the effective date for its reverse stock split. SciSparc Ltd. (NASDAQ:SPRC) gained 120.9% as it reported its 1-for-26 reverse share split is expected to be implemented after market close. Rite Aid Corporation (NYSE:RAD) climbed 44% following a substantial settlement agreement of $230 million by consulting firm McKinsey & Company related to opioid addiction lawsuits. On the other hand, Sharps Technology, Inc. (NASDAQ:STSS) fell 31.6% after reporting a $5.6 million registered direct and private placement priced at the market under Nasdaq rules.

Portfolio Pulse from Lisa Levin

September 27, 2023 | 4:48 pm

During Wednesday's pre-market session, several healthcare stocks saw significant movement. Galecto (GLTO), MSP Recovery (LIFW), Cardiff Oncology (CRDF), Intelligent Bio Solutions (INBS), Biohaven (BHVN), and Eledon Pharma (ELDN) all saw increases, with Galecto leading the gainers with a 31.3% increase. On the other hand, Know Labs (KNW), Minerva Surgical (UTRS), Femasys (FEMY), Tharimmune (THAR), DMK Pharmaceuticals (DMK), and Adial Pharmaceuticals (ADIL) all experienced decreases, with Know Labs leading the losers with a 36.5% decrease.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 1:06 pm

Several healthcare stocks experienced significant movement in Tuesday's after-market session. Galecto, Exagen, MSP Recovery, Brainstorm Cell, VYNE Therapeutics, and Freeline Therapeutics saw increases, while Minerva Surgical, Femasys, DMK Pharmaceuticals, Adial Pharmaceuticals, Tharimmune, and SeqLL experienced decreases.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 9:31 pm

The article lists the stocks that gained and lost the most in Friday's mid-day session. Notable gainers include Alset Capital Acquisition Corp., YS Biopharma Co., Ltd., and Crown ElectroKinetics Corp. On the other hand, Domo, Inc., Prime Number Acquisition I Corp., and Allego N.V. were among the biggest losers. Nordstrom, Inc. also fell by 9.5% following its Q2 results where total company net sales declined 8.3% YoY.

Portfolio Pulse from Lisa Levin

August 25, 2023 | 5:33 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.